Antipodes Partners’s StoneCo STNE Stock Holding History

Antipodes Partners’s Portfolio STNE Stock Details STNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,575	Closed	-$644K	–	150
2026 Q1	$644K	Buy	+45,575	New	+$700K	0.01%	80

Other funds holding STNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Squadra Investments Rio De Janeiro, Brazil $815M AUM 15.03% 1-Year Est. Return

PCP

Polunin Capital Partners London, United Kingdom $407M AUM 55.12% 1-Year Est. Return

SGDR

SPX Gestao de Recursos Rio De Janeiro, Brazil $898M AUM 45.5% 1-Year Est. Return

Antipodes Partners's STNE Position: Q2 2026 in Review

Antipodes Partners sold out of StoneCo (STNE) in Q2 2026, closing a stake of 45,575 shares — an estimated $644K sold.

Antipodes Partners first reported a position in STNE in Q1 2026 and held it in 1 quarter. The position peaked at $644K in Q1 2026. 272 funds tracked by Wall St. Rank hold STNE as of Q2 2026.

Antipodes Partners reported no remaining StoneCo position as of Q2 2026 after selling out during the quarter.
Antipodes Partners sold 45,575 StoneCo shares in Q2 2026, an estimated $644K.
Antipodes Partners first reported a position in StoneCo in Q1 2026 and held it in 1 quarter.
Antipodes Partners's StoneCo position peaked at $644K in Q1 2026.
272 funds tracked by Wall St. Rank held StoneCo as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.